Developer docs
API playgroundTry for free, no card

Search company profiles

Issar Pharmaceuticals

Full company profile

uuid00055a7

Namestring
Issar Pharmaceuticals
Legal namestring
Issar Pharmaceuticals
Websiteurl
issar.co.in
Company typeenum
Private
Founded yearint
1995
Descriptiontext

Issar Pharmaceuticals is a privately held medical drug development company founded in 1995, headquartered in Hyderabad, India. It operates with a workforce of 101–250 employees and is positioned within India's pharmaceutical R&D ecosystem in Hyderabad — a major hub for drug discovery, formulation development, and contract research. The company is for-profit, not publicly listed, and maintains a web presence at issar.co.in.

The substantive business profile of Issar Pharmaceuticals — including its specific therapeutic areas, drug pipeline candidates, development stage, technology platform, regulatory filings, intellectual property, and commercialization strategy — is not disclosed in the available source material. The primary corporate website returned only a loading/verification placeholder rather than substantive content, and no product details, leadership team, partnerships, certifications, or financial statements were available in the input data. The sole quantified capital event on record is a $3.83M funding round in February 2019, with investors undisclosed.

As a result, this analysis is necessarily constrained by a thin evidence base. What can be stated with reasonable confidence is limited to the firmographic footprint: an Indian pharma R&D entity of mid-small scale (101–250 staff), privately held, founded nearly three decades ago, with limited recent public capital formation activity visible in the supplied data. Investors evaluating Issar should treat the absence of pipeline, leadership, and financial disclosure as a material due diligence gap.

Short descriptiontext

Issar Pharmaceuticals is a privately held medical drug development company founded in 1995 and headquartered in Hyderabad, India, employing 101–250 staff. It operates within India's pharmaceutical R&D sector, though its specific pipeline, therapeutic focus, and commercial activities are not publicly disclosed.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHyderabad, India
HQ citystring
Hyderabad
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
pharmaceutical drug development, medical formulations, pharmaceutical research, drug discovery, medicinal products
Industry1 code
PRIMARYHLAIAAAF
Neurology & Psychiatry (CNS) Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Pharmaceutical Drug Development
Social media profiles1 record
Cost components3 values
Personnel, Technology or R&D, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Issar Pharmaceuticals is a medical drug development company engaged in pharmaceutical research and the creation of drug formulations. Headquartered in Hyderabad, India, and founded in 1995, the company operates in the pharmaceutical sector with 101–250 employees.

Differentiator
Functional benefit
Problem solved
Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight1 record

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major Indian pharmaceutical company with a broad drug development and formulations business including CNS products, providing a comparable broad-incumbent reference point in the same geography as Issar.

TypeBroad incumbent
Description

Global pharmaceutical major with extensive CNS and neurology product franchises, comparable to Issar as a broad incumbent reference in the same therapeutic categories at global scale.

TypeRegional player
Description

India-headquartered pharmaceutical company with a specialty and CNS franchise including migraine and neurology products, comparable to Issar as a regional player in overlapping therapeutic categories.

4Sun Pharmaceutical Industries
TypeBroad incumbent
Description

India's largest pharmaceutical company with a broad CNS and specialty product portfolio, comparable to Issar as a broad incumbent in Indian pharma with overlapping therapeutic categories and substantially greater scale.

TypeRegional player
Description

India-based mid-cap pharmaceutical company with drug development programs across CNS and specialty indications, comparable to Issar in geographic positioning and mid-sized stage profile.

6Suven Life Sciences
TypeDirect peer
Description

India-based pharmaceutical company historically focused on CNS drug development including depression, dementia, and migraine indications, making it the closest direct peer to Issar in therapeutic focus, geography, and stage profile.

TypeBroad incumbent
Description

Large India-based pharmaceutical group with CNS and neurology products, broad formulations portfolio, and active drug development programs; comparable to Issar as a broad incumbent in the same geography and overlapping therapeutic areas.

TypeBroad incumbent
Description

One of India's largest pharmaceutical companies with a broad CNS and formulations portfolio; a broad incumbent peer operating in the same therapeutic areas and Indian market as Issar, but at materially larger scale.

TypeBroad incumbent
Description

Global pharmaceutical major with a leading CNS portfolio including depression and migraine therapies, providing a broad incumbent reference point for the CNS therapeutic areas that Issar targets.

TypeRegional player
Description

India-headquartered mid-cap pharmaceutical company with a CNS product portfolio and operations across formulations and generics, comparable to Issar as an India-based peer with overlapping therapeutic categories and similar scale tier.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Issar Pharmaceuticals

Pharmaceutical Drug Developmentissar.co.in

Issar Pharmaceuticals is a privately held medical drug development company founded in 1995 and headquartered in Hyderabad, India, employing 101–250 staff. It operates within India's pharmaceutical R&D sector, though its specific pipeline, therapeutic focus, and commercial activities are not publicly disclosed.

What Issar Pharmaceuticals does

Issar Pharmaceuticals is a privately held medical drug development company founded in 1995, headquartered in Hyderabad, India. It operates with a workforce of 101–250 employees and is positioned within India's pharmaceutical R&D ecosystem in Hyderabad — a major hub for drug discovery, formulation development, and contract research. The company is for-profit, not publicly listed, and maintains a web presence at issar.co.in.

The substantive business profile of Issar Pharmaceuticals — including its specific therapeutic areas, drug pipeline candidates, development stage, technology platform, regulatory filings, intellectual property, and commercialization strategy — is not disclosed in the available source material. The primary corporate website returned only a loading/verification placeholder rather than substantive content, and no product details, leadership team, partnerships, certifications, or financial statements were available in the input data. The sole quantified capital event on record is a $3.83M funding round in February 2019, with investors undisclosed.

As a result, this analysis is necessarily constrained by a thin evidence base. What can be stated with reasonable confidence is limited to the firmographic footprint: an Indian pharma R&D entity of mid-small scale (101–250 staff), privately held, founded nearly three decades ago, with limited recent public capital formation activity visible in the supplied data. Investors evaluating Issar should treat the absence of pipeline, leadership, and financial disclosure as a material due diligence gap.

Issar Pharmaceuticals firmographics

Firmographics
Name
Issar Pharmaceuticals
Legal name
Issar Pharmaceuticals
Website
https://issar.co.in
Company type
Private
Founded year
1995
Headcount range
11–50 employees
Short description
Issar Pharmaceuticals is a privately held medical drug development company founded in 1995 and headquartered in Hyderabad, India, employing 101–250 staff. It operates within India's pharmaceutical R&D sector, though its specific pipeline, therapeutic focus, and commercial activities are not publicly disclosed.
Ownership category
akta.pro rank

Issar Pharmaceuticals industry classification

Industry
Product category
Pharmaceutical Drug Development
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIAAAF
Neurology & Psychiatry (CNS) Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Pharmaceutical drug development
  • Medical formulations
  • Pharmaceutical research
  • Drug discovery
  • Medicinal products

Where Issar Pharmaceuticals is headquartered

Location

Headquarters

HQ city
Hyderabad
HQ country
India
HQ region
Asia

Markets served

Issar Pharmaceuticals business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations

Issar Pharmaceuticals product offering

Product offering

Core offering

Issar Pharmaceuticals is a medical drug development company engaged in pharmaceutical research and the creation of drug formulations. Headquartered in Hyderabad, India, and founded in 1995, the company operates in the pharmaceutical sector with 101–250 employees.

Differentiator

Problem solved

Functional benefit

Companies that use Issar Pharmaceuticals

Customer profile

Ideal customer profiles1 record

Issar Pharmaceuticals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Issar Pharmaceuticals partnerships and signals

Strategic signal

Recent moves1 record

Expansion highlights1 record

Issar Pharmaceuticals competitors and assessment

Company assessment

Broad incumbents

  • Cipla Limited: Major Indian pharmaceutical company with a broad drug development and formulations business including CNS products, providing a comparable broad-incumbent reference point in the same geography as Issar.
  • Pfizer: Global pharmaceutical major with extensive CNS and neurology product franchises, comparable to Issar as a broad incumbent reference in the same therapeutic categories at global scale.
  • Sun Pharmaceutical Industries: India's largest pharmaceutical company with a broad CNS and specialty product portfolio, comparable to Issar as a broad incumbent in Indian pharma with overlapping therapeutic categories and substantially greater scale.
  • Zydus Lifesciences (Cadila): Large India-based pharmaceutical group with CNS and neurology products, broad formulations portfolio, and active drug development programs; comparable to Issar as a broad incumbent in the same geography and overlapping therapeutic areas.
  • Lupin Limited: One of India's largest pharmaceutical companies with a broad CNS and formulations portfolio; a broad incumbent peer operating in the same therapeutic areas and Indian market as Issar, but at materially larger scale.
  • Eli Lilly: Global pharmaceutical major with a leading CNS portfolio including depression and migraine therapies, providing a broad incumbent reference point for the CNS therapeutic areas that Issar targets.

Regional players

  • Glenmark Pharmaceuticals: India-headquartered pharmaceutical company with a specialty and CNS franchise including migraine and neurology products, comparable to Issar as a regional player in overlapping therapeutic categories.
  • Natco Pharma: India-based mid-cap pharmaceutical company with drug development programs across CNS and specialty indications, comparable to Issar in geographic positioning and mid-sized stage profile.
  • Torrent Pharmaceuticals: India-headquartered mid-cap pharmaceutical company with a CNS product portfolio and operations across formulations and generics, comparable to Issar as an India-based peer with overlapping therapeutic categories and similar scale tier.

Direct peers

  • Suven Life Sciences: India-based pharmaceutical company historically focused on CNS drug development including depression, dementia, and migraine indications, making it the closest direct peer to Issar in therapeutic focus, geography, and stage profile.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

Issar Pharmaceuticals social profiles

Digital presence

Issar Pharmaceuticals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Issar Pharmaceuticals leadership team

Management profile

Number of profiles

Issar Pharmaceuticals funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Issar Pharmaceuticals M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Issar Pharmaceuticals

What does Issar Pharmaceuticals do?

Issar Pharmaceuticals is a medical drug development company engaged in pharmaceutical research and the creation of drug formulations. Headquartered in Hyderabad, India, and founded in 1995, the company operates in the pharmaceutical sector with 101–250 employees.

When was Issar Pharmaceuticals founded?

Issar Pharmaceuticals was founded in 1995. It employs 11 to 50 people.

Where is Issar Pharmaceuticals based?

Issar Pharmaceuticals is headquartered in Hyderabad, India, in the Asia region.

Who are Issar Pharmaceuticals's main competitors?

Broad incumbents on record are Cipla Limited, Pfizer, Sun Pharmaceutical Industries, Zydus Lifesciences (Cadila), Lupin Limited and Eli Lilly. Regional players are Glenmark Pharmaceuticals, Natco Pharma and Torrent Pharmaceuticals. Suven Life Sciences is listed as a direct peer.

Does Issar Pharmaceuticals have an API?

No public API is recorded for Issar Pharmaceuticals.

What industry is Issar Pharmaceuticals in?

Issar Pharmaceuticals's product category is Pharmaceutical Drug Development. Its primary akta.pro industry code is HLAIAAAF, Neurology & Psychiatry (CNS) Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals